12 results on '"Colmenero, Jordi"'
Search Results
2. GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study
- Author
-
Rodríguez-Perálvarez, Manuel Luis, de la Rosa, Gloria, Gómez-Orellana, Antonio Manuel, Aguilera, María Victoria, Pascual Vicente, Teresa, Pereira, Sheila, Ortiz, María Luisa, Pagano, Giulia, Suarez, Francisco, González Grande, Rocío, Cachero, Alba, Tomé, Santiago, Barreales, Mónica, Martín Mateos, Rosa, Pascual, Sonia, Romero, Mario, Bilbao, Itxarone, Alonso Martín, Carmen, Otón, Elena, González Diéguez, Luisa, Espinosa, María Dolores, Arias Milla, Ana, Blanco Fernández, Gerardo, Lorente, Sara, Cuadrado Lavín, Antonio, Redín García, Amaya, Sánchez Cano, Clara, Cepeda-Franco, Carmen, Pons, José Antonio, Colmenero, Jordi, Guijo-Rubio, David, Otero, Alejandra, Amador Navarrete, Alberto, Romero Moreno, Sarai, Rodríguez Soler, María, Hervás Martínez, César, and Gastaca, Mikel
- Published
- 2024
- Full Text
- View/download PDF
3. Long-Term Outcomes of Incidental Liver Malignancies in Simultaneous Liver-Kidney Transplant Recipients
- Author
-
Rodríguez-Espinosa, Diana, Morantes, Laura, García, Jenmy, Broseta, José Jesús, Cuadrado-Payán, Elena, Colmenero, Jordi, Torregrosa, Josep Vicens, Diekmann, Fritz, and Esforzado, Nuria
- Published
- 2024
- Full Text
- View/download PDF
4. Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current Controversies.
- Author
-
Mauro, Ezequiel, Sanduzzi-Zamparelli, Marco, Jutras, Gabrielle, Garcia, Raquel, Soler Perromat, Alexandre, Llarch, Neus, Holguin Arce, Victor, Ruiz, Pablo, Rimola, Jordi, Lopez, Eva, Ferrer-Fàbrega, Joana, García-Criado, Ángeles, Colmenero, Jordi, Lai, Jennifer C., and Forner, Alejandro
- Subjects
PATIENT selection ,PUBLIC health surveillance ,NURSES ,OCCUPATIONAL roles ,CANCER relapse ,SURVIVAL rate ,FRAIL elderly ,IMMUNOTHERAPY ,CANCER patients ,TREATMENT effectiveness ,ALLIED health personnel ,NURSE practitioners ,MEDICAL radiology ,HEPATOCELLULAR carcinoma ,LIVER transplantation ,COMORBIDITY ,IMMUNOSUPPRESSION ,HEALTH care teams - Abstract
Simple Summary: Liver transplantation (LT) is one of the primary treatments for hepatocellular carcinoma (HCC) and significantly improves patient survival. However, the application of LT for HCC faces challenges owing to advancements in cancer-specific treatments and increased patient comorbidities. This review explores the current controversies and advancements in LT for HCC, focusing on managing comorbidities, the impact of frailty, selection criteria, the role of radiology, and the potential use of immunotherapy. We emphasize the importance of immunosuppression management and surveillance for HCC recurrence. A multidisciplinary approach is crucial to optimize the outcomes of patients with HCC undergoing LT, ensuring comprehensive care and improved survival rates. Liver transplantation (LT) remains one of the most effective treatments for hepatocellular carcinoma (HCC) and significantly enhances patient survival. However, the application of LT for HCC faces challenges owing to advancements in cancer-specific treatment modalities and the increased burden of patients' comorbidities. This narrative review explores current controversies and advancements in LT for HCC. Key areas of focus include the management of comorbidities and patient education by advanced practice nurses, impacts of frailty on waitlists and post-LT outcomes, selection criteria for LT in the era of new downstaging tools, role of radiology in patient selection, and implications of potential immunotherapy use both before and after LT. Additionally, the importance of immunosuppression management with strategies aimed at minimizing rejection while considering the risk of HCC recurrence and the role of surveillance for HCC recurrence is highlighted. This review also underscores the importance of a multidisciplinary approach for optimizing outcomes in patients with HCC undergoing LT. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. CACS, CCTA and mCAD‐LT score in the pre‐transplant assessment of coronary artery disease and the prediction of post‐transplant cardiovascular events.
- Author
-
Pagano, Giulia, Sastre, Lydia, Blasi, Annabel, Brugaletta, Salvatore, Mestres, Judit, Martinez‐Ocon, Julia, Ortiz‐Pérez, Jose T., Viñals, Clara, Prat‐Gonzàlez, Susanna, Rivas, Eva, Perea, Rosario J., Rodriguez‐Tajes, Sergio, Muxí, África, Ortega, Emilio, Doltra, Ada, Ruiz, Pablo, Vidal, Bàrbara, Martínez‐Palli, Graciela, Colmenero, Jordi, and Crespo, Gonzalo
- Subjects
CORONARY artery disease ,CORONARY artery calcification ,CORONARY angiography ,LIVER transplantation ,FAMILY history (Medicine) - Abstract
Background: The optimal cardiovascular assessment of liver transplant (LT) candidates is unclear. We aimed to evaluate the performance of CT‐based coronary tests (coronary artery calcium score [CACS] and coronary CT angiography [CCTA]) and a modification of the CAD‐LT score (mCAD‐LT, excluding family history of CAD) to diagnose significant coronary artery disease (CAD) before LT and predict the incidence of post‐LT cardiovascular events (CVE). Methods: We retrospectively analysed a single‐centre cohort of LT candidates who underwent non‐invasive tests; invasive coronary angiography (ICA) was performed depending on the results of non‐invasive tests. mCAD‐LT was calculated in all patients. Results: Six‐hundred‐and‐thirty‐four LT candidates were assessed and 351 of them underwent LT. CACS, CCTA and ICA were performed in 245, 123 and 120 LT candidates, respectively. Significant CAD was found in 30% of patients undergoing ICA. The AUROCs of mCAD‐LT (.722) and CCTA (.654) were significantly higher than that of CACS (.502) to predict the presence of significant CAD. Specificity of the tests ranged between 31% for CCTA and 53% for CACS. Among patients who underwent LT, CACS ≥ 400 and mCAD‐LT were independently associated with the incidence of CVE; in patients who underwent CCTA before LT, significant CAD at CCTA also predicted post‐LT CVE. Conclusion: In this cohort, mCAD‐LT score and CT‐based tests detect the presence of significant CAD in LT candidates, although they tend to overestimate it. Both mCAD‐LT score and CT‐based tests classify LT recipients according to their risk of post‐LT CVE and can be used to improve post‐LT risk mitigation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Focusing on Ischemic Reperfusion Injury in the New Era of Dynamic Machine Perfusion in Liver Transplantation
- Author
-
Chullo, Gabriela, Panisello-Roselló, Arnau, Marquez, Noel, Colmenero, Jordi, Brunet, Merce, Pera, Miguel, Roselló-Catafau, Joan, Bataller, Ramon, García-Valdecasas, Juan Carlos, Fundora, Yiliam, Chullo, Gabriela, Panisello-Roselló, Arnau, Marquez, Noel, Colmenero, Jordi, Brunet, Merce, Pera, Miguel, Roselló-Catafau, Joan, Bataller, Ramon, García-Valdecasas, Juan Carlos, and Fundora, Yiliam
- Abstract
Liver transplantation is the most effective treatment for end-stage liver disease. Transplant indications have been progressively increasing, with a huge discrepancy between the supply and demand of optimal organs. In this context, the use of extended criteria donor grafts has gained importance, even though these grafts are more susceptible to ischemic reperfusion injury (IRI). Hepatic IRI is an inherent and inevitable consequence of all liver transplants; it involves ischemia-mediated cellular damage exacerbated upon reperfusion and its severity directly affects graft function and post-transplant complications. Strategies for organ preservation have been constantly improving since they first emerged. The current gold standard for preservation is perfusion solutions and static cold storage. However, novel approaches that allow extended preservation times, organ evaluation, and their treatment, which could increase the number of viable organs for transplantation, are currently under investigation. This review discusses the mechanisms associated with IRI, describes existing strategies for liver preservation, and emphasizes novel developments and challenges for effective organ preservation and optimization.
- Published
- 2024
7. Risk Factors for Non-Adherence to Medication for Liver Transplant Patients: An Umbrella Review.
- Author
-
Colmenero, Jordi, Gastaca, Mikel, Martínez-Alarcón, Laura, Soria, Cristina, Lázaro, Esther, and Plasencia, Inmaculada
- Subjects
- *
LIVER transplantation , *PATIENT compliance , *TRANSPLANTATION of organs, tissues, etc. , *SOCIODEMOGRAPHIC factors , *UMBRELLAS - Abstract
Background/Objectives: Liver Transplantation (LT) is the second most common solid organ transplantation. Medication adherence on LT patients is key to avoiding graft failure, mortality, and important quality of life losses. The aim of this study is to identify risk-factors for non-adherence to treatment of liver transplant patients according to reliable published evidence. Methods: An umbrella review within the context of adherence to immunosuppressant medication of LT patients, was conducted. The review was performed in accordance with the principles of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines. Results: A total of 11 articles were finally included for the review. Non-adherence factors were identified and allocated using the WHO classification of factors for non-adherence. Each of these groups contains a subset of factors that have been shown to influence adherence to medication, directly or indirectly, according to literature findings. Conclusions: The results of the review indicate that sociodemographic factors, factors related to the patient, factors related to the treatment, condition-related and health system-related factors are good categories of predictors for both adherence and non-adherence to immunosuppressive medication in LT patients. This list of factors may help physicians in the treating and recognizing of patients with a potential risk of non-adherence and it could help in the designing of new tools to better understand non-adherence after LT and targeted interventions to promote adherence of LT patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. TOP-002 Validation of the gender-equity model for liver allocation (GEMA) in a nationwide cohort of liver transplant candidates in Spain
- Author
-
Rodríguez-Perálvarez, Manuel, de la Rosa, Gloria, Gómez-Orellana, Antonio M., Sancho, Victoria Aguilera, Pascual-Vicente, Teresa, Pereira, Sheila, Ortiz, María Luisa, Pagano, Giulia, Suárez, Francisco, González-Grande, Rocio, Cachero, Alba, Tomé, Santiago, Valbuena, Mónica Barreales, Martin-Mateos, Rosa, Pascual, Sonia, Cristóbal, Mario Romero, Bilbao, Itxarone, Martin, Carmen Alonso, Oton, Elena, Dieguez, Maria Luisa Gonzalez, Aguilar, María Dolores Espinosa, Arias, Ana, Blanco, Gerardo, Perez, Sara Lorente, Cuadrado, Antonio, García, Amaya Redín, Cano, Clara Sánchez, Franco, Carmen Cepeda, Pons, Jose Antonio, Colmenero, Jordi, Ferreiro, Alejandra Otero, Aretxabaleta, Nerea Hernández, Moreno, Sarai Romero, Soler, Maria Rodriguez, Hervás, César, and Gastaca, Mikel
- Published
- 2024
- Full Text
- View/download PDF
9. First consensus document of waiting list prioritization for liver transplantation by the Spanish Society of Liver Transplantation (SETH).
- Author
-
Bilbao I, Lladó L, Cachero A, Campos-Varela I, Colmenero J, Del Hoyo J, Fábrega García E, García-Pajares F, González Diéguez L, González Grande R, Guiberteau Sánchez A, Hernández Oliveros F, Herrero Santos JI, Lorente S, Martín Mateos R, Mesa López MJ, Montero Álvarez JL, Muñoz Codoceo C, Otero Ferreiro A, Otón Nieto E, Rodríguez Soler M, Romero Cristóbal M, Sastre Oliver L, Senosiain Labiano M, Sousa Martín JM, Trapero-Marugán M, Varo E, de la Rosa G, and Rodríguez-Perálvarez M
- Abstract
Spain is worldwide leader in deceased donation rates per million habitants and count on a strong network of twenty-five liver transplant institutions. Although the access to liver transplantation is higher than in other countries, approximately 10% of patients qualifying for liver transplantation in Spain will die in the waiting list or would be excluded due to clinical deterioration. A robust waiting list prioritization system is paramount to grant the sickest patients with the first positions in the waiting list for an earlier access to transplant. In addition, the allocation policy may not create or perpetuate inequities, particularly in a public and universal healthcare system. Hitherto, Spain lacks a unique national allocation system for elective liver transplantation. Most institutions establish their own rules for liver allocation and only two autonomous regions, namely Andalucía and Cataluña, share part of their waiting list within their territory to provide regional priority to patients requiring more urgent transplantation. This heterogeneity is further aggravated by the recently described sex-based disparities for accessing liver transplantation in Spain, and by the expansion of liver transplant indications, mainly for oncological indications, in absence of clear guidance on the optimal prioritization policy. The present document contains the recommendations from the first consensus of waiting list prioritization for liver transplantation issued by the Spanish Society of Liver Transplantation (SETH). The document was supported by all liver transplant institutions in Spain and by the Organización Nacional de Trasplantes (ONT). Its implementation will allow to homogenize practices and to improve equity and outcomes among patients with end-stage liver disease.
- Published
- 2024
- Full Text
- View/download PDF
10. Focusing on Ischemic Reperfusion Injury in the New Era of Dynamic Machine Perfusion in Liver Transplantation.
- Author
-
Chullo G, Panisello-Rosello A, Marquez N, Colmenero J, Brunet M, Pera M, Rosello-Catafau J, Bataller R, García-Valdecasas JC, and Fundora Y
- Subjects
- Humans, Perfusion, Reperfusion, Cryopreservation, Liver Transplantation, Reperfusion Injury
- Abstract
Liver transplantation is the most effective treatment for end-stage liver disease. Transplant indications have been progressively increasing, with a huge discrepancy between the supply and demand of optimal organs. In this context, the use of extended criteria donor grafts has gained importance, even though these grafts are more susceptible to ischemic reperfusion injury (IRI). Hepatic IRI is an inherent and inevitable consequence of all liver transplants; it involves ischemia-mediated cellular damage exacerbated upon reperfusion and its severity directly affects graft function and post-transplant complications. Strategies for organ preservation have been constantly improving since they first emerged. The current gold standard for preservation is perfusion solutions and static cold storage. However, novel approaches that allow extended preservation times, organ evaluation, and their treatment, which could increase the number of viable organs for transplantation, are currently under investigation. This review discusses the mechanisms associated with IRI, describes existing strategies for liver preservation, and emphasizes novel developments and challenges for effective organ preservation and optimization.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.